HEALTHEURACTIV
EU drug pricing: Belgium backs coordination push as Greece urges biotech scale-up [Advocacy Lab]
Belgium supports a coordinated European approach to address US demands on medicine pricing, while Greece advocates for accelerating biotech scale-up. The article highlights divergent EU member state strategies in responding to drug pricing pressures and biotechnology development.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- FIRST AID: EU divided over biotech incentives
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative